• レポートコード:QFJ1-5588 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、解熱鎮痛薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(パラセタモール、アスピリン、イブプロフェン、ノプロキシン、ジクロフェナク、その他)、用途別市場規模(大人用、子供用)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・解熱鎮痛薬の市場動向 ・企業の競争状況、市場シェア ・解熱鎮痛薬の種類別市場規模と予測2016-2027(パラセタモール、アスピリン、イブプロフェン、ノプロキシン、ジクロフェナク、その他) ・解熱鎮痛薬の用途別市場規模と予測2016-2027(大人用、子供用) ・解熱鎮痛薬の北米市場規模2016-2027(アメリカ、カナダ) ・解熱鎮痛薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・解熱鎮痛薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・解熱鎮痛薬の中南米市場規模2016-2027(メキシコ、ブラジル) ・解熱鎮痛薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Bayer、Actavis、Mylan、Pfizer、Novartis、Horizon Pharma、Iroko Pharmaceuticals、Hoechst、Xinhua Pharm、Teva、Hebei Jiheng) ・結論 |
A type of medicine that reduces fever and eases the pain.
Market Analysis and Insights: Global Antipyretic Analgesics Market
The global Antipyretic Analgesics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antipyretic Analgesics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antipyretic Analgesics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antipyretic Analgesics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antipyretic Analgesics market.
Global Antipyretic Analgesics Scope and Market Size
Antipyretic Analgesics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antipyretic Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Noproxen
Diclofenac
Others
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer
Actavis
Mylan
Pfizer
Novartis
Horizon Pharma
Iroko Pharmaceuticals
Hoechst
Xinhua Pharm
Teva
Hebei Jiheng
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipyretic Analgesics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Noproxen
1.2.6 Diclofenac
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antipyretic Analgesics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antipyretic Analgesics Market Perspective (2016-2027)
2.2 Antipyretic Analgesics Growth Trends by Regions
2.2.1 Antipyretic Analgesics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antipyretic Analgesics Historic Market Share by Regions (2016-2021)
2.2.3 Antipyretic Analgesics Forecasted Market Size by Regions (2022-2027)
2.3 Antipyretic Analgesics Industry Dynamic
2.3.1 Antipyretic Analgesics Market Trends
2.3.2 Antipyretic Analgesics Market Drivers
2.3.3 Antipyretic Analgesics Market Challenges
2.3.4 Antipyretic Analgesics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipyretic Analgesics Players by Revenue
3.1.1 Global Top Antipyretic Analgesics Players by Revenue (2016-2021)
3.1.2 Global Antipyretic Analgesics Revenue Market Share by Players (2016-2021)
3.2 Global Antipyretic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antipyretic Analgesics Revenue
3.4 Global Antipyretic Analgesics Market Concentration Ratio
3.4.1 Global Antipyretic Analgesics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipyretic Analgesics Revenue in 2020
3.5 Antipyretic Analgesics Key Players Head office and Area Served
3.6 Key Players Antipyretic Analgesics Product Solution and Service
3.7 Date of Enter into Antipyretic Analgesics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipyretic Analgesics Breakdown Data by Type
4.1 Global Antipyretic Analgesics Historic Market Size by Type (2016-2021)
4.2 Global Antipyretic Analgesics Forecasted Market Size by Type (2022-2027)
5 Antipyretic Analgesics Breakdown Data by Application
5.1 Global Antipyretic Analgesics Historic Market Size by Application (2016-2021)
5.2 Global Antipyretic Analgesics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antipyretic Analgesics Market Size (2016-2027)
6.2 North America Antipyretic Analgesics Market Size by Type
6.2.1 North America Antipyretic Analgesics Market Size by Type (2016-2021)
6.2.2 North America Antipyretic Analgesics Market Size by Type (2022-2027)
6.2.3 North America Antipyretic Analgesics Market Size by Type (2016-2027)
6.3 North America Antipyretic Analgesics Market Size by Application
6.3.1 North America Antipyretic Analgesics Market Size by Application (2016-2021)
6.3.2 North America Antipyretic Analgesics Market Size by Application (2022-2027)
6.3.3 North America Antipyretic Analgesics Market Size by Application (2016-2027)
6.4 North America Antipyretic Analgesics Market Size by Country
6.4.1 North America Antipyretic Analgesics Market Size by Country (2016-2021)
6.4.2 North America Antipyretic Analgesics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antipyretic Analgesics Market Size (2016-2027)
7.2 Europe Antipyretic Analgesics Market Size by Type
7.2.1 Europe Antipyretic Analgesics Market Size by Type (2016-2021)
7.2.2 Europe Antipyretic Analgesics Market Size by Type (2022-2027)
7.2.3 Europe Antipyretic Analgesics Market Size by Type (2016-2027)
7.3 Europe Antipyretic Analgesics Market Size by Application
7.3.1 Europe Antipyretic Analgesics Market Size by Application (2016-2021)
7.3.2 Europe Antipyretic Analgesics Market Size by Application (2022-2027)
7.3.3 Europe Antipyretic Analgesics Market Size by Application (2016-2027)
7.4 Europe Antipyretic Analgesics Market Size by Country
7.4.1 Europe Antipyretic Analgesics Market Size by Country (2016-2021)
7.4.2 Europe Antipyretic Analgesics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antipyretic Analgesics Market Size (2016-2027)
8.2 Asia-Pacific Antipyretic Analgesics Market Size by Type
8.2.1 Asia-Pacific Antipyretic Analgesics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antipyretic Analgesics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antipyretic Analgesics Market Size by Type (2016-2027)
8.3 Asia-Pacific Antipyretic Analgesics Market Size by Application
8.3.1 Asia-Pacific Antipyretic Analgesics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antipyretic Analgesics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antipyretic Analgesics Market Size by Application (2016-2027)
8.4 Asia-Pacific Antipyretic Analgesics Market Size by Region
8.4.1 Asia-Pacific Antipyretic Analgesics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antipyretic Analgesics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antipyretic Analgesics Market Size (2016-2027)
9.2 Latin America Antipyretic Analgesics Market Size by Type
9.2.1 Latin America Antipyretic Analgesics Market Size by Type (2016-2021)
9.2.2 Latin America Antipyretic Analgesics Market Size by Type (2022-2027)
9.2.3 Latin America Antipyretic Analgesics Market Size by Type (2016-2027)
9.3 Latin America Antipyretic Analgesics Market Size by Application
9.3.1 Latin America Antipyretic Analgesics Market Size by Application (2016-2021)
9.3.2 Latin America Antipyretic Analgesics Market Size by Application (2022-2027)
9.3.3 Latin America Antipyretic Analgesics Market Size by Application (2016-2027)
9.4 Latin America Antipyretic Analgesics Market Size by Country
9.4.1 Latin America Antipyretic Analgesics Market Size by Country (2016-2021)
9.4.2 Latin America Antipyretic Analgesics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipyretic Analgesics Market Size (2016-2027)
10.2 Middle East & Africa Antipyretic Analgesics Market Size by Type
10.2.1 Middle East & Africa Antipyretic Analgesics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antipyretic Analgesics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antipyretic Analgesics Market Size by Type (2016-2027)
10.3 Middle East & Africa Antipyretic Analgesics Market Size by Application
10.3.1 Middle East & Africa Antipyretic Analgesics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antipyretic Analgesics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antipyretic Analgesics Market Size by Application (2016-2027)
10.4 Middle East & Africa Antipyretic Analgesics Market Size by Country
10.4.1 Middle East & Africa Antipyretic Analgesics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antipyretic Analgesics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Antipyretic Analgesics Introduction
11.1.4 Bayer Revenue in Antipyretic Analgesics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Actavis
11.2.1 Actavis Company Details
11.2.2 Actavis Business Overview
11.2.3 Actavis Antipyretic Analgesics Introduction
11.2.4 Actavis Revenue in Antipyretic Analgesics Business (2016-2021)
11.2.5 Actavis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Antipyretic Analgesics Introduction
11.3.4 Mylan Revenue in Antipyretic Analgesics Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antipyretic Analgesics Introduction
11.4.4 Pfizer Revenue in Antipyretic Analgesics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antipyretic Analgesics Introduction
11.5.4 Novartis Revenue in Antipyretic Analgesics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Antipyretic Analgesics Introduction
11.6.4 Horizon Pharma Revenue in Antipyretic Analgesics Business (2016-2021)
11.6.5 Horizon Pharma Recent Development
11.7 Iroko Pharmaceuticals
11.7.1 Iroko Pharmaceuticals Company Details
11.7.2 Iroko Pharmaceuticals Business Overview
11.7.3 Iroko Pharmaceuticals Antipyretic Analgesics Introduction
11.7.4 Iroko Pharmaceuticals Revenue in Antipyretic Analgesics Business (2016-2021)
11.7.5 Iroko Pharmaceuticals Recent Development
11.8 Hoechst
11.8.1 Hoechst Company Details
11.8.2 Hoechst Business Overview
11.8.3 Hoechst Antipyretic Analgesics Introduction
11.8.4 Hoechst Revenue in Antipyretic Analgesics Business (2016-2021)
11.8.5 Hoechst Recent Development
11.9 Xinhua Pharm
11.9.1 Xinhua Pharm Company Details
11.9.2 Xinhua Pharm Business Overview
11.9.3 Xinhua Pharm Antipyretic Analgesics Introduction
11.9.4 Xinhua Pharm Revenue in Antipyretic Analgesics Business (2016-2021)
11.9.5 Xinhua Pharm Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Antipyretic Analgesics Introduction
11.10.4 Teva Revenue in Antipyretic Analgesics Business (2016-2021)
11.10.5 Teva Recent Development
11.11 Hebei Jiheng
11.11.1 Hebei Jiheng Company Details
11.11.2 Hebei Jiheng Business Overview
11.11.3 Hebei Jiheng Antipyretic Analgesics Introduction
11.11.4 Hebei Jiheng Revenue in Antipyretic Analgesics Business (2016-2021)
11.11.5 Hebei Jiheng Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Antipyretic Analgesics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Paracetamol
Table 3. Key Players of Aspirin
Table 4. Key Players of Ibuprofen
Table 5. Key Players of Noproxen
Table 6. Key Players of Diclofenac
Table 7. Key Players of Others
Table 8. Global Antipyretic Analgesics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antipyretic Analgesics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Antipyretic Analgesics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Antipyretic Analgesics Market Share by Regions (2016-2021)
Table 12. Global Antipyretic Analgesics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Antipyretic Analgesics Market Share by Regions (2022-2027)
Table 14. Antipyretic Analgesics Market Trends
Table 15. Antipyretic Analgesics Market Drivers
Table 16. Antipyretic Analgesics Market Challenges
Table 17. Antipyretic Analgesics Market Restraints
Table 18. Global Antipyretic Analgesics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Antipyretic Analgesics Market Share by Players (2016-2021)
Table 20. Global Top Antipyretic Analgesics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Analgesics as of 2020)
Table 21. Ranking of Global Top Antipyretic Analgesics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Antipyretic Analgesics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antipyretic Analgesics Product Solution and Service
Table 25. Date of Enter into Antipyretic Analgesics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Antipyretic Analgesics Revenue Market Share by Type (2016-2021)
Table 29. Global Antipyretic Analgesics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Antipyretic Analgesics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Antipyretic Analgesics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Antipyretic Analgesics Revenue Market Share by Application (2016-2021)
Table 33. Global Antipyretic Analgesics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Antipyretic Analgesics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Antipyretic Analgesics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Antipyretic Analgesics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Antipyretic Analgesics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Antipyretic Analgesics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Antipyretic Analgesics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Antipyretic Analgesics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Antipyretic Analgesics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Antipyretic Analgesics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Antipyretic Analgesics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Antipyretic Analgesics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antipyretic Analgesics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antipyretic Analgesics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Antipyretic Analgesics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Antipyretic Analgesics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Antipyretic Analgesics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Antipyretic Analgesics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Antipyretic Analgesics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Antipyretic Analgesics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Antipyretic Analgesics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Antipyretic Analgesics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antipyretic Analgesics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antipyretic Analgesics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antipyretic Analgesics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Antipyretic Analgesics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Antipyretic Analgesics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Antipyretic Analgesics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Antipyretic Analgesics Product
Table 68. Bayer Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Actavis Company Details
Table 71. Actavis Business Overview
Table 72. Actavis Antipyretic Analgesics Product
Table 73. Actavis Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 74. Actavis Recent Development
Table 75. Mylan Company Details
Table 76. Mylan Business Overview
Table 77. Mylan Antipyretic Analgesics Product
Table 78. Mylan Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 79. Mylan Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Antipyretic Analgesics Product
Table 83. Pfizer Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Antipyretic Analgesics Product
Table 88. Novartis Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Horizon Pharma Company Details
Table 91. Horizon Pharma Business Overview
Table 92. Horizon Pharma Antipyretic Analgesics Product
Table 93. Horizon Pharma Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 94. Horizon Pharma Recent Development
Table 95. Iroko Pharmaceuticals Company Details
Table 96. Iroko Pharmaceuticals Business Overview
Table 97. Iroko Pharmaceuticals Antipyretic Analgesics Product
Table 98. Iroko Pharmaceuticals Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 99. Iroko Pharmaceuticals Recent Development
Table 100. Hoechst Company Details
Table 101. Hoechst Business Overview
Table 102. Hoechst Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 103. Hoechst Recent Development
Table 104. Xinhua Pharm Company Details
Table 105. Xinhua Pharm Business Overview
Table 106. Xinhua Pharm Antipyretic Analgesics Product
Table 107. Xinhua Pharm Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 108. Xinhua Pharm Recent Development
Table 109. Teva Company Details
Table 110. Teva Business Overview
Table 111. Teva Antipyretic Analgesics Product
Table 112. Teva Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 113. Teva Recent Development
Table 114. Hebei Jiheng Company Details
Table 115. Hebei Jiheng Business Overview
Table 116. Hebei Jiheng Antipyretic Analgesics Product
Table 117. Hebei Jiheng Revenue in Antipyretic Analgesics Business (2016-2021) & (US$ Million)
Table 118. Hebei Jiheng Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antipyretic Analgesics Market Share by Type: 2020 VS 2027
Figure 2. Paracetamol Features
Figure 3. Aspirin Features
Figure 4. Ibuprofen Features
Figure 5. Noproxen Features
Figure 6. Diclofenac Features
Figure 7. Others Features
Figure 8. Global Antipyretic Analgesics Market Share by Application: 2020 VS 2027
Figure 9. Adult Case Studies
Figure 10. Child Case Studies
Figure 11. Antipyretic Analgesics Report Years Considered
Figure 12. Global Antipyretic Analgesics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Antipyretic Analgesics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antipyretic Analgesics Market Share by Regions: 2020 VS 2027
Figure 15. Global Antipyretic Analgesics Market Share by Regions (2022-2027)
Figure 16. Global Antipyretic Analgesics Market Share by Players in 2020
Figure 17. Global Top Antipyretic Analgesics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Analgesics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Antipyretic Analgesics Revenue in 2020
Figure 19. Global Antipyretic Analgesics Revenue Market Share by Type (2016-2021)
Figure 20. Global Antipyretic Analgesics Revenue Market Share by Type (2022-2027)
Figure 21. North America Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Antipyretic Analgesics Market Share by Type (2016-2027)
Figure 23. North America Antipyretic Analgesics Market Share by Application (2016-2027)
Figure 24. North America Antipyretic Analgesics Market Share by Country (2016-2027)
Figure 25. United States Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Antipyretic Analgesics Market Share by Type (2016-2027)
Figure 29. Europe Antipyretic Analgesics Market Share by Application (2016-2027)
Figure 30. Europe Antipyretic Analgesics Market Share by Country (2016-2027)
Figure 31. Germany Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Antipyretic Analgesics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Antipyretic Analgesics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Antipyretic Analgesics Market Share by Region (2016-2027)
Figure 41. China Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Antipyretic Analgesics Market Share by Type (2016-2027)
Figure 49. Latin America Antipyretic Analgesics Market Share by Application (2016-2027)
Figure 50. Latin America Antipyretic Analgesics Market Share by Country (2016-2027)
Figure 51. Mexico Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Antipyretic Analgesics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Antipyretic Analgesics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Antipyretic Analgesics Market Share by Country (2016-2027)
Figure 57. Turkey Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Antipyretic Analgesics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 61. Actavis Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 65. Horizon Pharma Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 66. Iroko Pharmaceuticals Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 67. Hoechst Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 68. Xinhua Pharm Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 69. Teva Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 70. Hebei Jiheng Revenue Growth Rate in Antipyretic Analgesics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed